A study of the availability of six commercial formulations of isoniazid.
D001702:Biopharmaceutics; D004339:Drug Compounding; D006801:Humans; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D007538:Isoniazid / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000592:standards; D007700:Kinetics; D008297:Male; D013607:Tablets; D013810:Therapeutic Equivalency; D013997:Time Factors
D013607:Tablets; D007538:Isoniazid